FDA Inspection 1203046 — Xavier Saez-Llorens M.D.
The FDA completed an inspection of Xavier Saez-Llorens M.D. on March 24, 2023 in Tocumen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 24, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Tocumen (Panama)
Additional Details
Clinical Investigator (CI)